HIGHClinicalTier 1
Surgical Therapy for Peri‐Implantitis Using Deproteinised Bovine Bone Mineral With 10% Collagen, Enamel Matrix Derivative and Doxycycline: A Prospective Cohort 10‐Year Implant Study
SourceJournal of Clinical PeriodontologyTier 1Peer-Reviewed Research
By Faustino Mercado, Saso Ivanovski
Originally at onlinelibrary.wiley.com
Summary & scoring by The Bell Brief (Dr. Jennifer Bell) using the Drill-Down Protocol (Drill-Down Score) — not the original publisher.
Why it matters for dental
This 10-year prospective cohort study introduces a specific regenerative protocol (DBBM+10% collagen + EMD + doxycycline) that may become a new clinical standard for peri-implantitis surgery, directly affecting implant survival rates and long-term practice revenue.
Key points
- 10-year data on implant survival and bone stability using the DBBM-collagen + EMD + doxycycline combination in peri-implantitis defects.
- Protocol includes a single systemic doxycycline course and local enamel matrix derivative application—requires updated surgical consent language and antibiotic stewardship compliance.
- Specialist and periodontal practices treating moderate-to-advanced peri-implantitis cases may see improved implant retention rates versus historical debridement-alone approaches.
- Long-term results could influence payer coverage decisions for regenerative peri-implant procedures and alter DSO surgical referral patterns.
Who should care
SpecialistOwnerAssociate
Read the original on Journal of Clinical Periodontology
Full reporting and any paywall content live on onlinelibrary.wiley.com. We summarize and score; we do not republish.